Financials
- Market Capitalization 394.54 M
- Employee 75
- Founded 2021
- CEO N/A
- Website www.upstreambio.com
- Headquarter Delaware, United States
- FIGI BBG017Y2X923
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-10.21
Relación precio/flujo de caja
512.3
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2854 | EIKN Eikon Therapeutics, Inc. - Common Stock | 10.34 USD | -0.96% | -13.04% | +8.61% | -39.35% | 559.79 M USD | ||
| 3021 | CBIO Crescent Biopharma, Inc. - Common Stock | 15.88 USD | +1.21% | -6.26% | -10.94% | +24.06% | 437.84 M USD | ||
| 3236 | QTTB Q32 Bio Inc. - Common Stock | 19.75 USD | -7.62% | +42.50% | +54.54% | +872.91% | 334.89 M USD | ||
| 3329 | AMRN Amarin Corporation plc - American Depositary Shares, each repre | 14.59 USD | -0.75% | -5.69% | -4.64% | -6.23% | 305.94 M USD |